Details of the Drug

General Information of Drug (ID: DMO1NMJ)

Drug Name

GS-9669

Synonyms

Radalbuvir; GS-9669; UNII-273K4V0SPC; 273K4V0SPC; 1314795-11-3; Radalbuvir [INN]; SCHEMBL19607380; SCHEMBL15252930; SCHEMBL15252929; SCHEMBL12444696; CHEMBL3121539; SB16766; DB12065; 2-Thiophenecarboxylic acid, 5-(3,3-dimethyl-1-butyn-1-yl)-3-((cis-4-hydroxy-4-((((3S)-tetrahydro-3-furanyl)oxy)methyl)cyclohexyl)(((1R)-4-methyl-3-cyclohexen-1-yl)carbonyl)amino)-; 5-(3,3-dimethylbut-1-ynyl)-3-[[4-hydroxy-4-[[(3S)-tetrahydrofuran-3-yl]oxymethyl]cyclohexyl]-[(1R)-4-methylcyclohex-3-ene-1-carbonyl]amino]thiophene-2-carboxylic

Indication

Disease Entry	ICD 11	Status	REF
Chronic HCV-1 infection	1E51.1	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C30H41NO6S
Canonical SMILES: CC1=CCC(CC1)C(=O)N(C2CCC(CC2)(COC3CCOC3)O)C4=C(SC(=C4)C#CC(C)(C)C)C(=O)O
InChI: 1S/C30H41NO6S/c1-20-5-7-21(8-6-20)27(32)31(25-17-24(11-13-29(2,3)4)38-26(25)28(33)34)22-9-14-30(35,15-10-22)19-37-23-12-16-36-18-23/h5,17,21-23,35H,6-10,12,14-16,18-19H2,1-4H3,(H,33,34)/t21-,22?,23-,30?/m0/s1
InChIKey: MUICUPWICXUNRS-UVXQUXCMSA-N

Cross-matching ID

PubChem CID: 53259022
CAS Number: 1314795-11-3
TTD ID: D0W1JJ

References

1	ClinicalTrials.gov (NCT01260350) Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naive Patients With HCV GT2 or GT3. U.S. National Institutes of Health.